We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.1B
AUM Growth
+$362M
Cap. Flow
-$1.11B
Cap. Flow %
-3.25%
Top 10 Hldgs %
15.48%
Holding
3,181
New
192
Increased
947
Reduced
1,799
Closed
170

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$63.9M
2
MSFT icon
Microsoft
MSFT
+$31.4M
3
IBM icon
IBM
IBM
+$23.4M
4
XOM icon
ExxonMobil
XOM
+$23M
5
PFE icon
Pfizer
PFE
+$18.3M

Sector Composition

Rank Sector Weight
1 Financials 14.59%
2 Technology 14.25%
3 Healthcare 13.21%
4 Industrials 11.1%
5 Energy 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOPN icon
2501
Kopin
KOPN
$652M
$347K ﹤0.01%
106,464
-3,320
-3% -$10.9K
OSPN icon
2502
OneSpan
OSPN
$574M
$347K ﹤0.01%
29,907
-8,180
-21% -$85K
PGTI
2503
DELISTED
PGT, Inc.
PGTI
$346K ﹤0.01%
40,849
+13,910
+52% +$130K
PACB icon
2504
Pacific Biosciences
PACB
$435M
$345K ﹤0.01%
55,821
-12,673
-19% -$63.4K
VSEC icon
2505
VSE Corp
VSEC
$5.45B
$345K ﹤0.01%
9,804
-180
-2% -$5.59K
PGNX
2506
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$344K ﹤0.01%
79,793
+27,914
+54% +$107K
GOOD
2507
Gladstone Commercial Corp
GOOD
$605M
$343K ﹤0.01%
19,182
+620
+3% +$10.9K
BFX
2508
DELISTED
BowFlex Inc.
BFX
$343K ﹤0.01%
30,928
+2,283
+8% +$23.1K
PEBO icon
2509
Peoples Bancorp
PEBO
$1.5B
$342K ﹤0.01%
12,946
-300
-2% -$7.57K
PFBC icon
2510
Preferred Bank
PFBC
$1.24B
$342K ﹤0.01%
14,448
-340
-2% -$7.9K
PERY
2511
DELISTED
Perry Ellis International Inc
PERY
$342K ﹤0.01%
19,597
-630
-3% -$9.95K
TSC
2512
DELISTED
TriState Capital Holdings, Inc.
TSC
$341K ﹤0.01%
+24,108
New +$329K
PNX
2513
DELISTED
PHOENIX COMPANIES INC. NEW
PNX
$341K ﹤0.01%
7,042
-322
-4% -$14.8K
OME
2514
DELISTED
Omega Protein
OME
$340K ﹤0.01%
24,853
+857
+4% +$11.2K
TBHC
2515
DELISTED
The Brand House Collective
TBHC
$339K ﹤0.01%
18,299
+545
+3% +$9.59K
RMAX icon
2516
RE/MAX Holdings
RMAX
$193M
$339K ﹤0.01%
11,465
+3,465
+43% +$98.1K
KEM
2517
DELISTED
KEMET Corporation
KEM
$339K ﹤0.01%
58,942
-2,330
-4% -$13K
LXRX icon
2518
Lexicon Pharmaceuticals
LXRX
$1.03B
$338K ﹤0.01%
29,978
-197
-0.7% -$2.12K
ECHO
2519
DELISTED
Echo Global Logistics, Inc.
ECHO
$338K ﹤0.01%
17,610
+2,410
+16% +$44.2K
RPRX
2520
DELISTED
Repros Therapeutics Inc.
RPRX
$338K ﹤0.01%
19,520
+779
+4% +$12.7K
BN icon
2521
Brookfield
BN
$104B
$336K ﹤0.01%
32,612
MGA icon
2522
Magna International
MGA
$18.7B
$336K ﹤0.01%
6,240
HWCC
2523
DELISTED
Houston Wire & Cable Company
HWCC
$336K ﹤0.01%
27,106
+280
+1% +$3.42K
XNPT
2524
DELISTED
XENOPORT, INC.
XNPT
$336K ﹤0.01%
69,493
+6,050
+10% +$25.7K
MG icon
2525
Mistras Group
MG
$484M
$335K ﹤0.01%
13,682
-282
-2% -$6.47K

Similar funds

RhumbLine Advisers's Q2 2014 Portfolio in Review

As of Q2 2014, RhumbLine Advisers held 3,181 positions worth $34.1B, up 1.1% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers withdrew a net $1.11B in Q2 2014, closing 170 positions and reducing 1,799 holdings. Its most notable exit was BEAM INC COM STK (DE), an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in Navient worth $10M.

  • RhumbLine Advisers's largest Q2 2014 buy was Navient: 566,289 shares worth $10M.
  • RhumbLine Advisers added most to American Airlines Group in Q2 2014, an estimated $22.1M increase.
  • RhumbLine Advisers's biggest Q2 2014 reduction was Apple, cutting an estimated $63.9M.
  • RhumbLine Advisers fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $18.3M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $34.1B portfolio in Q2 2014.
  • RhumbLine Advisers opened 192 new positions and closed 170 in Q2 2014.
  • RhumbLine Advisers's portfolio value rose 1.1% quarter-over-quarter to $34.1B.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.